Clinical Hepatology - Principles and Practice of Hepatobiliary Diseases provides clear and comprehensive coverage of the etiology, mechanisms of disease, diagnosis, and practical management of the entire spectrum of liver and biliary disorders. It also affords an excellent, evidence-based review of the rapidly expanding field of hepatobiliary diseases.

Henryk Dancygier is Chief of the Department of Medicine II at the Klinikum Offenbach, and Professor of Medicine at the Goethe University, Frankfurt/Main. He graduated from the University of Heidelberg and trained in Pathology, Internal Medicine, Gastroenterology and Hepatology. He holds degrees from the University of Heidelberg, Frankfurt and the Technical University of Munich and currently is Adjunct Professor of Medicine at the Mount Sinai School of Medicine, New York.

Henryk Dancygier is author of a number of books including (English translations) 'AIDS - a Clinical Compendium' (1993), 'Memorix - Gastroenterology and Hepatology' (1998), 'Endosonography in Gastroenterology: Principles, Techniques, Findings' (1999), 'Liver Diseases - the ABC of Therapy' (2003) and 'Clinical Hepatology - Diagnosis and Therapy of Hepatobiliary Disorders' (2003) that have been translated into several languages and he has also contributed numerous chapters in Medical Textbooks.

1;Copyright Page;4 2;Dedication;5 3;Foreword;6 4;Preface;7 5;Volume 2;9 6;Contents of Volume 2;14 7;Contributors;19 8;Part IV: Diseases of the Liver;26 8.1;Section X: Developmental Anomalies;27 8.1.1;Chapter 55;28 8.1.1.1;Malformations and Malpositions of the Liver;28 8.1.1.1.1;Riedel's Lobe;28 8.1.1.1.2;Accessory Liver Lobe(s);28 8.1.1.1.3;Ectopy;28 8.1.1.1.4;Extraabdominal Location of the Liver;29 8.1.1.1.5;Intraabdominal Displacement of the Liver;29 8.1.1.1.6;Agenesis;29 8.1.1.1.7;Atrophy;29 8.1.1.1.8;Zahn's Grooves;29 8.1.1.1.9;"Corset Liver";29 8.1.1.1.10;References;30 8.1.2;Chapter 56;31 8.1.2.1;Bile Duct Anomalies;31 8.1.2.1.1;Congenital Liver Fibrosis;31 8.1.2.1.2;Caroli's Disease and Caroli's Syndrome;33 8.1.2.1.2.1;Defi nition;33 8.1.2.1.2.2;Pathogenesis;33 8.1.2.1.2.3;Pathology;33 8.1.2.1.2.4;Diagnosis;33 8.1.2.1.2.4.1;Clinical Manifestations;33 8.1.2.1.2.4.2;Technical Examinations;33 8.1.2.1.2.4.3;Differential Diagnosis;33 8.1.2.1.2.4.4;Course and Prognosis;33 8.1.2.1.2.4.5;Therapy;34 8.1.2.1.3;Von Meyenburg Complexes;34 8.1.2.1.4;Biliary Atresia;34 8.1.2.1.4.1;Defi nition;34 8.1.2.1.4.2;Epidemiology;35 8.1.2.1.4.3;Etiology and Pathogenesis;35 8.1.2.1.4.4;Pathology;35 8.1.2.1.4.5;Diagnosis;35 8.1.2.1.4.5.1;Clinical Manifestations;35 8.1.2.1.4.5.2;Technical Examinations;36 8.1.2.1.4.6;Prognosis and Treatment;36 8.1.2.1.4.7;References;36 8.1.3;Chapter 57;37 8.1.3.1;Liver Cysts and Polycystic Liver Disease;37 8.1.3.1.1;Liver Cysts;37 8.1.3.1.1.1;Defi nition;37 8.1.3.1.1.2;Epidemiology;37 8.1.3.1.1.3;Etiology;38 8.1.3.1.1.4;Pathogenesis;38 8.1.3.1.1.5;Diagnosis;38 8.1.3.1.1.5.1;Clinical Manifestations;38 8.1.3.1.1.5.2;Technical Examinations;38 8.1.3.1.1.6;Differential Diagnosis;38 8.1.3.1.1.7;Complications;39 8.1.3.1.1.8;Natural History and Prognosis;39 8.1.3.1.1.9;Therapy;39 8.1.3.1.2;Polycystic Liver Disease;39 8.1.3.1.2.1;Defi nition;39 8.1.3.1.2.2;Epidemiology;39 8.1.3.1.2.3;Etiology and Pathogenesis;39 8.1.3.1.2.4;Pathology;40 8.1.3.1.2.5;Diagnosis;40 8.1.3.1.2.5.1;Clinical Manifestations;40 8.1.3.1.2.5.2;Technical Examinations;40 8.1.3.1.2.6;Natural History and Prognosis;40 8.1.3.1.2.7;Therapy;40 8.1.3.1.2.8;References;41 8.1.4;Chapter 58;42 8.1.4.1;Vascular Anomalies;42 8.1.4.2;References;43 8.2;Section XI: Circulatory and Vascular Disorders;44 8.2.1;Chapter 59;45 8.2.1.1;Hepatic Veins;45 8.2.1.1.1;Acute Hepatic Congestion;45 8.2.1.1.2;Chronic Hepatic Congestion;45 8.2.1.1.3;Budd-Chiari Syndrome;46 8.2.1.1.3.1;Defi nition;46 8.2.1.1.3.2;Epidemiology;46 8.2.1.1.3.3;Etiology and Pathogenesis;46 8.2.1.1.3.4;Pathology;48 8.2.1.1.3.5;Diagnosis;48 8.2.1.1.3.5.1;Clinical Manifestations;48 8.2.1.1.3.5.2;Laboratory Findings;48 8.2.1.1.3.5.3;Imaging Techniques;48 8.2.1.1.3.6;Prognosis and Treatment;49 8.2.1.1.4;Central Hyaline Sclerosis;49 8.2.1.1.5;Prolapse of Hepatocytes into the Central Veins;50 8.2.1.1.6;References;50 8.2.2;Chapter 60;52 8.2.2.1;Sinusoids;52 8.2.2.1.1;Sinusoidal Dilatation;52 8.2.2.1.2;Peliosis Hepatis;53 8.2.2.1.2.1;Defi nition;53 8.2.2.1.2.2;Epidemiology;53 8.2.2.1.2.3;Etiology and Pathogenesis;53 8.2.2.1.2.4;Pathology;53 8.2.2.1.2.5;Diagnosis;53 8.2.2.1.2.5.1;Signs and Symptoms;53 8.2.2.1.2.5.2;Laboratory Parameters;53 8.2.2.1.2.5.3;Imaging Techniques;53 8.2.2.1.2.6;Therapy and Prognosis;54 8.2.2.1.3;Sinusoidal Obstruction Syndrome;54 8.2.2.1.3.1;Defi nition;54 8.2.2.1.3.2;Epidemiology;54 8.2.2.1.3.3;Etiology and Pathogenesis;54 8.2.2.1.3.4;Pathology;55 8.2.2.1.3.5;Diagnosis;55 8.2.2.1.3.5.1;Signs and Symptoms;56 8.2.2.1.3.5.2;Laboratory Parameters;56 8.2.2.1.3.5.3;Imaging Techniques;56 8.2.2.1.3.6;Differential Diagnosis;56 8.2.2.1.3.7;Course and Prognosis;56 8.2.2.1.3.8;Treatment;56 8.2.2.1.4;Changes of Sinusoidal Contents;57 8.2.2.1.5;Perisinusoidal Lesions;57 8.2.2.1.6;References;58 8.2.3;Chapter 61;59 8.2.3.1;Portal Vein;59 8.2.3.1.1;Portal Vein Thrombosis;59 8.2.3.1.1.1;Acute Portal Vein Thrombosis;59 8.2.3.1.1.2;Chronic Portal Vein Thrombosis;60 8.2.4;Chapter 62;65 8.2.4.1;Hepatic Arteries;65